Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer
| Conditions: | Cancer |
| Start Date: | November 1, 2005 |
| Phase: | Phase II |
| Status: | Completed |
| NCT ID: | NCT00222729 |
| Study Type: | Interventional |
| Intervention: | Drug: Pemetrexed|Drug: Bevacizumab |
| Study Design: | Allocation: Non-Randomized|Control: Active Control|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | University of Pittsburgh|Eli Lilly and Company|Genentech |
| Ages: | Adult|Senior |
| Enrollment: | 20 |
| Funded By: | Other|Industry |
| First Received: | September 16, 2005 |
| End Date: | September 1, 2009 |
| Last Updated: | April 30, 2010 |
| Last Verified: | April 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
